Annual Short Term Debt
$3.31 M
+$436.00 K+15.18%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual short term debt is $3.31 million, with the most recent change of +$436.00 thousand (+15.18%) on December 31, 2023.
- During the last 3 years, KPTI annual short term debt has risen by +$1.39 million (+72.56%).
- KPTI annual short term debt is now at all-time high.
Performance
KPTI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$3.67 M
+$123.00 K+3.47%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly short term debt is $3.67 million, with the most recent change of +$123.00 thousand (+3.47%) on September 30, 2024.
- Over the past year, KPTI quarterly short term debt has increased by +$123.00 thousand (+3.47%).
- KPTI quarterly short term debt is now at all-time high.
Performance
KPTI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
KPTI Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +15.2% | +3.5% |
3 y3 years | +72.6% | +69.6% |
5 y5 years | +100.0% | +131.7% |
KPTI Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +42.8% | at high | +58.4% |
5 y | 5-year | at high | +101.0% | at high | +122.8% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Karyopharm Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.67 M(+3.5%) |
Jun 2024 | - | $3.54 M(+3.5%) |
Mar 2024 | - | $3.42 M(+3.5%) |
Dec 2023 | $3.31 M(+15.2%) | $3.31 M(+3.5%) |
Sep 2023 | - | $3.19 M(+3.6%) |
Jun 2023 | - | $3.08 M(+3.6%) |
Mar 2023 | - | $2.98 M(+3.7%) |
Dec 2022 | $2.87 M(+24.0%) | $2.87 M(+3.7%) |
Sep 2022 | - | $2.77 M(+5.9%) |
Jun 2022 | - | $2.62 M(+6.2%) |
Mar 2022 | - | $2.46 M(+6.3%) |
Dec 2021 | $2.32 M | $2.32 M(+7.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $2.16 M(+4.0%) |
Jun 2021 | - | $2.08 M(+4.1%) |
Mar 2021 | - | $2.00 M(+4.2%) |
Dec 2020 | $1.92 M(+16.5%) | $1.92 M(+3.8%) |
Sep 2020 | - | $1.85 M(+3.9%) |
Jun 2020 | - | $1.78 M(+3.9%) |
Mar 2020 | - | $1.71 M(+3.9%) |
Dec 2019 | $1.65 M(>+9900.0%) | $1.65 M(+4.0%) |
Sep 2019 | - | $1.58 M(+4.0%) |
Jun 2019 | - | $1.52 M(+10.7%) |
Mar 2019 | - | $1.38 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Karyopharm Therapeutics annual short term debt?
- What is the all time high annual short term debt for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual short term debt year-on-year change?
- What is Karyopharm Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly short term debt year-on-year change?
What is Karyopharm Therapeutics annual short term debt?
The current annual short term debt of KPTI is $3.31 M
What is the all time high annual short term debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual short term debt is $3.31 M
What is Karyopharm Therapeutics annual short term debt year-on-year change?
Over the past year, KPTI annual short term debt has changed by +$436.00 K (+15.18%)
What is Karyopharm Therapeutics quarterly short term debt?
The current quarterly short term debt of KPTI is $3.67 M
What is the all time high quarterly short term debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly short term debt is $3.67 M
What is Karyopharm Therapeutics quarterly short term debt year-on-year change?
Over the past year, KPTI quarterly short term debt has changed by +$123.00 K (+3.47%)